GILT Antibodies

Santa Cruz Biotechnology features a diverse variety of GILT monoclonal antibodies for advanced research in the field of immunology. GILT Antibodies are optimized for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GILT, or gamma-interferon-inducible lysosomal thiol reductase, plays a crucial role in the immune response by catalyzing the reduction of disulfide bonds in proteins, thereby enhancing antigen presentation. GILT is essential for the processing of certain antigens, which is vital for T cell activation and the overall adaptive immune response. Understanding GILT function is important for developing therapeutic strategies against various diseases, including infections and cancer. GILT research has revealed significant implications for autoimmune disorders and potential treatment approaches. Investigating GILT expression patterns helps researchers understand cellular responses to various stimuli and disease conditions. Current studies focusing on GILT continue to uncover new aspects of immune system regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of immunological processes and contribute to breakthrough discoveries in human health.